Evidence map›Paper›PMID 34911772›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2022

A System for In Vitro Generation of Mature Murine Plasma Cells Uncovers Differential

Emily Robinson, Matthew A Care, Kieran Walker, Michelle Campbell, Reuben M Tooze, Gina M Doody

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. EfficientImmune network · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emily RobinsonDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and.
Matthew A CareDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and.ORCID 0000-0001-6584-5889
Kieran WalkerDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and.ORCID 0000-0002-6694-2979
Michelle CampbellDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and.
Reuben M ToozeDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and.ORCID 0000-0003-2915-7119
Gina M DoodyDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, United Kingdom; and g.m.doody@leeds.ac.uk.ORCID 0000-0003-0665-6759
University of Leeds · GB

Funding

Cancer Research UK 17723Cancer Research UK 29212Cancer Research UK A17723Cancer Research UK A19349
6 · The paper itself

Abstract

Upon encounter with Ag, B cells undergo a sequential process of differentiation to become Ab-secreting plasma cells. Although the key drivers of differentiation have been identified, research has been limited by the lack of in vitro models recapitulating the full process for murine B cells. In this study, we describe methodology using BCR or TLR ligation to obtain plasma cells that are phenotypically mature, have exited cell cycle and express a gene signature concordant with long-lived plasma cells. Dependent on the initial stimuli, the transcriptomes also show variation including the enhanced expression of matrisome components after BCR stimulation, suggestive of unique functional properties for the resultant plasma cells. Moreover, using the new culture conditions we demonstrate that alternative promoter choice regulating the expression of the master transcription factor Blimp-1/Prdm1 can be observed; when the canonical B cell promoter for

Indexed as

AnimalsCell DifferentiationGene Expression RegulationMiceMice, Inbred C57BLPlasma CellsPositive Regulatory Domain I-Binding Factor 1Promoter Regions, GeneticReceptors, Antigen, B-CellTranscriptomePositive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseReceptors, Antigen, B-Cell

Identifiers

PMID34911772
PMCPMC7612223
OpenAlexW4200568387

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.